124 related articles for article (PubMed ID: 9577621)
1. [Contrast-enhanced power Doppler imaging of the liver--preliminary animal study].
Matsumura T; Moriyasu F; Kono Y; Chiba T
Nihon Rinsho; 1998 Apr; 56(4):985-9. PubMed ID: 9577621
[TBL] [Abstract][Full Text] [Related]
2. Gray scale second harmonic imaging of the liver: a preliminary animal study.
Kono Y; Moriyasu F; Nada T; Suginoshita Y; Matsumura T; Kobayashi K; Nakamura T; Chiba T
Ultrasound Med Biol; 1997; 23(5):719-26. PubMed ID: 9253819
[TBL] [Abstract][Full Text] [Related]
3. [Sonographic depiction of woodchuck hepatomas using intravenously injected contrast agents].
Nada T; Moriyasu F; Kono Y; Matsumura T
Nihon Rinsho; 1998 Apr; 56(4):980-4. PubMed ID: 9577620
[TBL] [Abstract][Full Text] [Related]
4. Vascularization of liver tumors - preliminary results with Coded Harmonic Angio (CHA), phase inversion imaging, 3D power Doppler and contrast medium-enhanced B-flow with second generation contrast agent (Optison).
Jung EM; Kubale R; Jungius KP; Jung W; Lenhart M; Clevert DA
Clin Hemorheol Microcirc; 2006; 34(4):483-97. PubMed ID: 16687788
[TBL] [Abstract][Full Text] [Related]
5. Sonographic detection of tumor blood flow using a new contrast agent in woodchuck hepatomas.
Nada T; Moriyasu F; Kono Y; Suginoshita Y; Matsumura T; Kobayashi K; Nakamura T; Chiba T
J Ultrasound Med; 1997 Jul; 16(7):485-91. PubMed ID: 9315200
[TBL] [Abstract][Full Text] [Related]
6. Flash-echo gray-scale imaging in the subtraction mode for assessing perfusion of small hepatocellular carcinoma.
Wang JH; Lu SN; Changchien CS; Huang WS; Hung CH; Tung HD; Chen TM; Lee CM
J Clin Ultrasound; 2003; 31(9):451-6. PubMed ID: 14595733
[TBL] [Abstract][Full Text] [Related]
7. [Contrast-enhanced ultrasound with Optison in percutaneous thermoablation of liver tumors].
Jung EM; Clevert DA; Rupp N
Rofo; 2003 Oct; 175(10):1403-12. PubMed ID: 14556110
[TBL] [Abstract][Full Text] [Related]
8. [The correlation between Doppler echography with a contrast medium and CT in the study of a hepatocarcinoma submitted to chemoembolization].
Catalano O; Cusati B; Esposito M; Trivellini V; Lobianco R; Siani A
Radiol Med; 1998 Jun; 95(6):608-13. PubMed ID: 9717543
[TBL] [Abstract][Full Text] [Related]
9. [Native and signal-enhanced power Doppler sonography for characterization of liver lesions].
Strunk H; Stuckmann G; Fröhlich E; Textor J; Wilhelm K; Hortling N; Remig J
Rofo; 1998 Apr; 168(4):344-51. PubMed ID: 9589096
[TBL] [Abstract][Full Text] [Related]
10. Harmonic hepatic US with microbubble contrast agent: initial experience showing improved characterization of hemangioma, hepatocellular carcinoma, and metastasis.
Wilson SR; Burns PN; Muradali D; Wilson JA; Lai X
Radiology; 2000 Apr; 215(1):153-61. PubMed ID: 10751481
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular carcinoma: power Doppler US with a contrast agent--preliminary results.
Kim AY; Choi BI; Kim TK; Han JK; Yun EJ; Lee KY; Han MC
Radiology; 1998 Oct; 209(1):135-40. PubMed ID: 9769824
[TBL] [Abstract][Full Text] [Related]
12. Flash echo gray scale imaging with subtraction in assessment of small hepatocellular carcinoma treated with percutaneous ethanol injection: preliminary report.
Wang JH; Lu SN; Changchien CS; Lee CM; Tung HD; Chen TM
J Ultrasound Med; 2001 May; 20(5):539-44. PubMed ID: 11345112
[TBL] [Abstract][Full Text] [Related]
13. Vascularity of hepatocellular carcinoma: assessment with contrast-enhanced second-harmonic versus conventional power Doppler US.
Choi BI; Kim TK; Han JK; Kim AY; Seong CK; Park SJ
Radiology; 2000 Feb; 214(2):381-6. PubMed ID: 10671584
[TBL] [Abstract][Full Text] [Related]
14. Gray-scale second harmonic imaging of the liver with galactose-based microbubbles.
Kono Y; Moriyasu F; Mine Y; Nada T; Kamiyama N; Suginoshita Y; Matsumura T; Kobayashi K; Chiba T
Invest Radiol; 1997 Feb; 32(2):120-5. PubMed ID: 9039585
[TBL] [Abstract][Full Text] [Related]
15. Tissue-specific US contrast agent for evaluation of hepatic and splenic parenchyma.
Forsberg F; Goldberg BB; Liu JB; Merton DA; Rawool NM; Shi WT
Radiology; 1999 Jan; 210(1):125-32. PubMed ID: 9885597
[TBL] [Abstract][Full Text] [Related]
16. Sonographic evaluation of focal nodular hyperplasias (FNH) of the liver with a transpulmonary galactose-based contrast agent (Levovist).
Uggowitzer M; Kugler C; Gröll R; Mischinger HJ; Stacher R; Fickert P; Weiglein A
Br J Radiol; 1998 Oct; 71(850):1026-32. PubMed ID: 10211062
[TBL] [Abstract][Full Text] [Related]
17. Hepatic tumors: signal enhancement at Doppler US after intravenous injection of a contrast agent.
Goldberg BB; Hilpert PL; Burns PN; Liu JB; Newman LM; Merton DA; Witlin LA
Radiology; 1990 Dec; 177(3):713-7. PubMed ID: 2173841
[TBL] [Abstract][Full Text] [Related]
18. Characterization of malignant focal liver lesions with contrast-enhanced 40 MHz ultrasound imaging in hepatitis B virus X transgenic mice: a feasibility study.
Liao AH; Cheng YC; Weng CH; Tsai TF; Lin WH; Yeh SH; Yeh WC; Li PC
Ultrason Imaging; 2008 Oct; 30(4):203-16. PubMed ID: 19507674
[TBL] [Abstract][Full Text] [Related]
19. [Contrast enhanced power Doppler in evaluating the angiogenesis in hepatocellular carcinoma].
Xiao JD; Shen SR; Li RZ; Zhou P; Zhu WH
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Oct; 32(5):840-4. PubMed ID: 18007081
[TBL] [Abstract][Full Text] [Related]
20. Three-dimensional power Doppler sonography of tumor vascularity.
Hirai T; Ohishi H; Yamada R; Yoshimura H; Hirohashi S; Uchida H; Hashimoto H; Jibiki T; Takeuchi Y
Radiat Med; 1998; 16(5):353-7. PubMed ID: 9862157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
